Clinical Trial Update: Clinical Trial With Catheter Locking TauroSept® (Taurolidine 2%) or Saline Solution 0,9% [NA]

View source ↗

Summary

A completed clinical trial comparing TauroSept, a taurolidine 2% catheter locking solution, with normal saline for preventing catheter-related bloodstream infec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Catheter-related Bloodstream Infection

Drugs mentioned

• Normal saline 0.9% (sodium chloride 0.9%)
• TauroSept (taurolidine)

Snippet

Sponsor: Geert Wanten | Conditions: Catheter Related Blood Stream Infections | NA | Status: COMPLETED